Company: GANX
Filing Date: 2025-04-10
Form Type: 8-K
Source: 0001104659-25-033797
Chunk: 3

Company: Gain Therapeutics, Inc.
Filing Date: 2025-04-10
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits

  99.1      Press Release dated April 10,                      
            2025.                                              
 ───────────────────────────────────────────────────────────────
  99.2      Investor Presentation.                             
   104      Cover Page Interactive                             

Signature

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                             GAIN THERAPEUTICS, INC.                               
  Dated: April 10, 2025      By:                          /s/                      
                                                          Gene Mack                
                                                          Chief Executive Officer